AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 41; Title 49; Title 53; Title 63; Title 68 and Title 71, relative to psychotropic medication.
Summary
HB1160 requires the Tennessee Department of Health to prepare and submit a report by January 1, 2026 identifying each drug classified as a psychotropic medication under Tennessee law and listing the side effects of each drug. The report must be delivered to the chairs of the Senate Health and Welfare Committee and the House committee with jurisdiction over health-related matters. The bill does not change prescribing rules, eligibility standards, or treatment requirements; it is a reporting measure focused on compiling and transmitting information to legislative committees.
The bill references the existing statutory definition of “psychotropic medication” in Tennessee Code Annotated § 49-2-124 and would operate across multiple titles listed in the caption, but its substantive effect is limited to the Department of Health’s reporting obligation. Because it is framed as a one-time informational report, the bill’s practical impact would be to create an official state inventory of psychotropic drugs and their side effects for legislative review and oversight.
Impact
HB1160 would add a new administrative duty for the Department of Health without directly amending treatment standards, criminal law, education policy, or licensing rules. Its effect on state law is to require a report on psychotropic medications and their side effects, using the statutory definition already found in Tennessee law, and to send that report to specified legislative committee chairs. The bill would primarily affect the Department of Health and legislative committees overseeing health-related matters, rather than patients, providers, or regulated industries directly.
Sentiment
The available voting history suggests limited support in committee, as the bill failed in the House Health Subcommittee by a vote of 3-5. No committee transcript is provided, so there is no recorded debate to indicate broader support or opposition arguments. Overall, the sentiment appears cautious or unfavorable in the subcommittee setting, likely reflecting concerns about the need for the report, its scope, or its policy implications, though the record does not specify the reasons.
Contention
The main point of contention appears to be whether the Department of Health should be required to compile and report detailed information on psychotropic medications and their side effects. Potential concerns may include administrative burden, duplication of existing information, or the purpose of collecting the data for legislative oversight. Supporters would likely view the bill as a transparency and information-gathering measure, while opponents in subcommittee evidently were not persuaded that the reporting requirement was necessary or appropriate.
Crossfiled
AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 41; Title 49; Title 53; Title 63; Title 68 and Title 71, relative to psychotropic medication.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 41; Title 49; Title 53; Title 63; Title 68 and Title 71, relative to psychotropic medication.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 29; Title 33; Title 38; Title 39; Title 40; Title 41; Title 43; Title 45; Title 50; Title 53; Title 63; Title 67; Title 68 and Title 71, relative to cannabis.